Premium
Corbus Pharmaceuticals Holdings Inc (CRBP)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designe... Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.025 | -0.299222022741 | 8.355 | 9.41 | 7.64 | 484661 | 8.32663856 | CS |
| 4 | -2.27 | -21.4150943396 | 10.6 | 11.58 | 7.64 | 300255 | 9.38149243 | CS |
| 12 | -9.31 | -52.7777777778 | 17.64 | 18.89 | 7.64 | 280224 | 12.16624898 | CS |
| 26 | -49.84 | -85.6799037304 | 58.17 | 61.89 | 7.64 | 470328 | 20.56505211 | CS |
| 52 | -15.43 | -64.9410774411 | 23.76 | 61.9 | 7.64 | 376623 | 29.64193752 | CS |
| 156 | -1.96 | -19.0476190476 | 10.29 | 61.9 | 2.11 | 963113 | 10.54814336 | CS |
| 260 | -160.87 | -95.0768321513 | 169.2 | 322.5 | 2.11 | 2155920 | 57.79518606 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
